Western Blot: CXXC4 Antibody [NBP1-76491] - Human brain tissue lysate with CXXC4 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.
Immunohistochemistry-Paraffin: CXXC4 Antibody [NBP1-76491] - Human brain tissue with CXXC4 antibody at 10 ug/mL.
Immunofluorescence: CXXC4 Antibody [NBP1-76491] - Immunofluorescence of CXXC4 in human brain tissue with CXXC4 antibody at 20 ug/mL.
Antibody was raised against an 18 amino acid synthetic peptide near the amino terminus of human CXXC4. The immunogen is located within amino acids 50 - 100 of CXXC4. Amino Acid Squence: NLPERVGTFSAIPALGG
Isotype
IgG
Clonality
Polyclonal
Host
Rabbit
Gene
CXXC4
Purity
Peptide affinity purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer
PBS
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Purity
Peptide affinity purified
Alternate Names for CXXC4 Antibody - BSA Free
CXXC finger protein 4
CXXC-type zinc finger protein 4
Dvl-binding protein IDAX (inhibition of the Dvl and Axin complex)
IDAXCXXC finger 4
Inhibition of the Dvl and axin complex protein
MGC149872
Background
CXXC4 is zinc finger protein that binds directly to the PDZ domain of DVL1, a protein involved in the Wnt signaling pathway, through its C-terminal region. CXXC4's interaction with DVL1 competes with DVL1-AXIN binding, although the affinity of DVL1 for CXXC4 is lower than that for AXIN. In mouse fibroblasts, CXXC4 suppressed Wnt3a induction of beta-catenin and inhibited Wnt3a-dependent TCF4 activation, suggesting that CXXC4 acts as a negative regulator of the Wnt signaling pathway and functions between DVL and beta-catenin. Recent reports suggest that decreased CXXC4 expression is associated with kidney cancer metastasis, cell proliferation, reduced apoptosis in response to cancer drugs, and upregulation of genes involved with proliferation, invasion and cell survival, suggesting that CXXC4 plays a critical role in tumor progression in kidney cancer.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
We have publications tested in 1 confirmed species: Human.
We have publications tested in 1 application: WB.
Filter By Application
WB
(1)
All Applications
Filter By Species
Human
(1)
All Species
Showing Publication 1 - 1 of 1.
Publication using NBP1-76491
Applications
Species
Olofsen P, Fatrai S, van Strien P et al. Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia Cell Reports Medicine Jan 1 2020 (WB, Human)
WB
Human
Reviews for CXXC4 Antibody (NBP1-76491) (0)
There are no reviews for CXXC4 Antibody (NBP1-76491).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Bioinformatics Tool for CXXC4 Antibody (NBP1-76491)
Discover related pathways, diseases and genes to CXXC4 Antibody (NBP1-76491). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for CXXC4 Antibody (NBP1-76491)
Discover more about diseases related to CXXC4 Antibody (NBP1-76491).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our CXXC4 Antibody - BSA Free and receive a gift card or discount.